Selex and Its Recent Optimizations

Aptamers in Bioanalysis

Volumn , Issue , 2008, Pages 31-59

  Strehlitz, Beate ^a   Stoltenburg, Regina ^a  

^a HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

Author keywords

Aptamers and their selection by SELEX; Efficient immobilization of aptamers on surfaces construction of tough, stable sensors and assay systems; SELEX and recent optimizations

Indexed keywords

EID: 84865302818     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470380772.ch2     Document Type: Chapter

References (160)

1. Andre, C., Berthelot, A., Thomassin, M., Guillaume, Y. C. (2006). Enantioselective aptameric molecular recognition material: design of a novel chiral stationary phase for enantioseparation of a series of chiral herbicides by capillary electrochromatography. Electrophoresis 27, 3254-3262.
2. Andreola, M. L., Calmels, C., Michel, J., Toulmé, J-J., Litvak, S. (2000). Towards the selection of phosphorothioate aptamers: optimizing in vitro selection steps with phosphorothioate nucleotides. Eur J Biochem 267, 5032-5040.
3. Asai, R., Nishimura, S. I., Aita, T., Takahashi, K. (2004). In vitro selection of DNA aptamers on chips using a method for generating point mutations. Anal Lett 37, 645-656.
4. Baker, B. R., Lai, R. Y., Wood, M. S., Doctor, E. H., Heeger, A. J., Plaxco, K. W. (2006). An electronic, aptamer-based small-molecule sensor for the rapid, label-free detection of cocaine in adulterated samples and biological fluids. J Am Chem Soc 128, 3138-3139.
5. Berezovski, M., Musheev, M., Drabovich, A., Krylov, S. N. (2006). Non-SELEX selection of aptamers. J Am Chem Soc 128, 1410-1411.
6. Bianchini, M., Radrizzani, M., Brocardo, M. G., Reyes, G. B., Gonzalez, S. C., Santa-Coloma, T. A. (2001). Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein. J Immunol Methods 252, 191-197.
7. Bini, A., Minunni, M., Tombelli, S., Centi, S., Mascini, M. (2007). Analytical performances of aptamer-based sensing for thrombin detection. Anal Chem 79, 3016-3019.
8. Bittker, J. A., Le, B. V., Liu, D. R. (2002). Nucleic acid evolution and minimization by nonhomologous random recombination. Nat Biotechnol 20, 1024-1029.
9. Blank, M., Weinschenk, T., Priemer, M., Schluesener, H. (2001). Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels: selective targeting of endothelial regulatory protein pigpen. J Biol Chem 276, 16464-16468.
10. Bloquel, C., Bourges, J. L., Touchard, E., Berdugo, M., BenEzra, D., Behar-Cohen, F. (2006). Non-viral ocular gene therapy: potential ocular therapeutic avenues. Adv Drug Deliv Rev 58, 1224-1242.
11. Brody, E. N., Willis, M. C., Smith, J. D., Jayasena, S., Zichi, D., Gold, L. (1999). The use of aptamers in large arrays for molecular diagnostics. Mol Diagn 4, 381-388.
12. Burgstaller, P., Girod, A., Blind, M. (2002). Aptamers as tools for target prioritization and lead identification. Drug Discov Today 7, 1221-1228.
13. Burke, D. H., Willis, J. H. (1998). Recombination, RNA evolution, and bifunctional RNA molecules isolated through chimeric SELEX. RNA 4, 1165-1175.
14. Cassiday, L. A., Maher, L. J. (2003). Yeast genetic selections to optimize RNA decoys for transcription factor NF-kappa B. Proc Natl Acad Sci U S A 100, 3930-3935.
15. Cerchia, L., Duconge, F., Pestourie, C., Boulay, J., Aissouni, Y., Gombert, K., Tavitian, B., de Franciscis, V., Libri, D. (2005). Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLOS Biology 3, 697-704.
16. Chapman, J. A., Beckey, C. (2006). Pegaptanib: a novel approach to ocular neovascularization. Ann Pharmacother 40, 1322-1326.
17. Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., Farokhzad, O. C. (2007). Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28, 869-876.
18. Coulter, L. R., Landree, M. A., Cooper, T. A. (1997). Identification of a new class of exonic splicing enhancers by in vivo selection. Mol Cell Biol 17, 2143-2150.
19. Cox, J. C., Ellington, A. D. (2001). Automated selection of anti-protein aptamers. Bioorg Med Chem 9, 2525-2531.
20. Cox, J. C., Rajendran, M., Riedel, T., Davidson, E. A., Sooter, L. J., Bayer, T. S., Schmitz-Brown, M., Ellington, A. D. (2002). Automated acquisition of aptamer sequences. Comb Chem High Throughput Screen 5, 289-299.
21. Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M., Gold, L. (2003). A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A 100, 15416-15421.
22. Davis, K. A., Abrams, B., Lin, Y., Jayasena, S. D. (1996). Use of a high affinity DNA ligand in flow cytometry. Nucleic Acids Res 24, 702-706.
23. Dobbelstein, M., Shenk, T. (1995). In-vitro selection of RNA ligands for the ribosomal L22 protein associated with Epstein-Barr virus-expressed RNA by using randomized and CDNA-derived RNA libraries. J Virol 69, 8027-8034.
24. Dougan, H., Lyster, D. M., Vo, C. V., Stafford, A., Weitz, J. I., Hobbs, J. B. (2000). Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood. Nucl Med Biol 27, 289-297.
25. Drabovich, A. P., Berezovski, M., Okhonin, V., Krylov, S. N. (2006). Selection of smart aptamers by methods of kinetic capillary electrophoresis. Anal Chem 78, 3171-3178.
26. Dyke, C. K., Steinhubl, S. R., Kleiman, N. S., Cannon, R. O., Aberle, L. G., Lin, M., Myles, S. K., Melloni, C., Harrington, R. A., Alexander, J. H., Becker, R. C., Rusconi, C. P. (2006). First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity. Circulation 114, 2490-2497.
27. Ellington, A. D., Szostak, J. W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
28. Ellington, A. D., Szostak, J. W. (1992). Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 355, 850-852.
29. Eulberg, D., Klussmann, S. (2003). Spiegelmers: biostable aptamers. ChemBioChem 4, 979-983.
30. Eulberg, D., Buchner, K., Maasch, C., Klussmann, S. (2005). Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Res 33, e45.
31. Famulok, M., (1999). Oligonucleotide aptamers that recognize small molecules. Curr Opin Struct Biol 9, 324-329.
32. Famulok, M., Blind, M., Mayer, G. (2001). Intramers as promising new tools in functional proteomics. Chem Biol 8, 931-939.
33. Fattal, E., Bochot, A. (2006). Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Adv Drug Deliv Rev 58, 1203-1223.
34. Faulhammer, D., Eschgfaller, B., Stark, S., Burgstaller, P., Englberger, W., Erfurth, J., Kleinjung, F., Rupp, J., Vulcu, S. D., Schroder, W., Vonhoff, S., Nawrath, H., Gillen, C., Klussmann, S. (2004). Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ. RNA-A 10, 516-527.
35. Ferreira, C. S. M., Matthews, C. S., Missailidis, S. (2006). DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumor Biol 27, 289-301.
36. Geiger, A., Burgstaller, P., von der Eltz, H., Roeder, A., Famulok, M. (1996). RNA aptamers that bind l-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res 24, 1029-1036.
37. Gold, L., Brown, D., He, Y. Y., Shtatland, T., Singer, B. S., Wu, Y. (1997a). From oligonucleotide shapes to genomic SELEX: novel biological regulatory loops. Proc Natl Acad Sci U S A 94, 59-64.
38. Gold, L., Singer, B., He, Y. Y., Brody, E. (1997b). SELEX and the evolution of genomes. Curr Opin Genet Dev 7, 848-851.
39. Golden, M. C., Collins, B. D., Willis, M. C., Koch, T. H. (2000). Diagnostic potential of photoSELEX-evolved ssDNA aptamers. J Biotechnol 81, 167-178.
40. Gopinath, S. C., (2007). Methods developed for SELEX. Anal Bioanal Chem 387, 171-182.
41. Gopinath, S. C. B., Misono, T. S., Kawasaki, K., Mizuno, T., Imai, M., Odagiri, T., Kumar, P. K. R. (2006). An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J Gen Virol 87, 479-487.
42. Göringer, H. U., Homann, M., Lorger, M. (2003). In vitro selection of high-affinity nucleic acid ligands to parasite target molecules. Int J Parasitol 33, 1309-1317.
43. Green, L. S., Jellinek, D., Jenison, R., Ostman, A., Heldin, C. H., Janjic, N. (1996). Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 35, 14413-14424.
44. Guo, K., Wendel, H. P., Scheideler, L., Ziemer, G., Scheule, A. M. (2005). Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion. J Cell MolMed 9, 731-736.
45. Guo, K. T., Scharnweber, D., Schwenzer, B., Ziemer, G., Wendel, H. P. (2007). The effect of electrochemical functionalization of Ti-alloy surfaces by aptamer-based capture molecules on cell adhesion. Biomaterials 28, 468-474.
46. Guthold, M., Cubicciotti, R., Superfine, R., Taylor, R. M. (2002). Novel methodology to detect, isolate, amplify and characterize single aptamer molecules with desirable target-binding properties. Biophys J. Supplement, Abstract, 163C.
47. Guthrie, J. W., Hamula, C. L. A., Zhang, H. Q., Le, X. C. (2006). Assays for cytokines using aptamers. Methods 38, 324-330.
48. Haes, A. J., Giordano, B. C., Collins, G. E. (2006). Aptamer-based detection and quantitative analysis of ricin using affinity probe capillary electrophoresis. Anal Chem 78, 3758-3764.
49. Haller, A. A., Sarnow, P. (1997). In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proc Natl Acad Sci U S A 94, 8521-8526.
50. Held, D. M., Greathouse, S. T., Agrawal, A., Burke, D. H. (2003). Evolutionary landscapes for the acquisition of new ligand recognition by RNA aptamers. J Mol Evol 57, 299-308.
51. Hermann, T., Patel, D. J. (2000). Adaptive recognition by nucleic acid aptamers. Science 287, 820-825.
52. Herr, J. K., Smith, J. E., Medley, C. D., Shangguan, D. H., Tan, W. H. (2006). Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem 78, 2918-2924.
53. Hesselberth, J. R., Miller, D., Robertus, J., Ellington, A. D. (2000). In vitro selection of RNA molecules that inhibit the activity of ricin A-chain. J BiolChem 275, 4937-4942.
54. Hicke, B. J., Stephens, A. W., Gould, T., Chang, Y. F., Lynott, C. K., Heil, J., Borkowski, S., Hilger, C. S., Cook, G., Warren, S., Schmidt, P.G. (2006). Tumor targeting by an aptamer. J Nucl Med 47, 668-678.
55. Homann, M., Göringer, H. U. (1999). Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res 27, 2006-2014.
56. Huizenga, D. E., Szostak, J. W. (1995). A DNA aptamer that binds adenosine and ATP. Biochemistry 34, 656-665.
57. http://www.archemix.com.
58. http://www.isis-innovation.com.
59. http://www.noxxon.net.
60. http://www.somalogic.com/.
61. Hwang, B., Lee, S. W. (2002). Improvement of RNA aptamer activity against myasthenic autoantibodies by extended sequence selection. Biochem Biophys Res Commun 290, 656-662.
62. Hybarger, G., Bynum, J., Williams, R. F., Valdes, J. J., Chambers, J. P. (2006). A microfluidic SELEX prototype. Anal Bioanal Chem 384, 191-198.
63. Ireson, C. R., Kelland, L. R. (2006). Discovery and development of anticancer aptamers. Mol Cancer Ther 5, 2957-2962.
64. Ito, Y., Fukusaki, E. (2004). DNA as a 'nanomaterial'. J Mol Catal B 28, 155-166.
65. James, W. (2000). Aptamers. In Encyclopedia of Analytical Chemistry, R. A. Meyers, ed., Wiley, Chichester, UK, pp. 4848-4871.
66. Jayasena, S. D. (1999). Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45, 1628-1650.
67. Jellinek, D., Green, L. S., Bell, C., Janjic, N. (1994). Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. Biochemistry 33, 10450-10456.
68. Jenison, R. D., Gill, S. C., Pardi, A., Polisky, B. (1994). High-resolution molecular discrimination by RNA. Science 263, 1425-1429.
69. Jensen, K. B., Atkinson, B. L., Willis, M. C., Koch, T. H., Gold, L. (1995). Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci U S A 92, 12220-12224.
70. Jeon, S. H., Kayhan, B., Ben-Yedidia, T., Arnon, R. (2004). A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J Biol Chem 279, 48410-48419.
71. Jhaveri, S., Olwin, B., Ellington, A. D. (1998). In vitro selection of phosphorothiolated aptamers. Bioorg Med Chem Lett 8, 2285-2290.
72. Jhaveri, S., Rajendran, M., Ellington, A. D. (2000). In vitro selection of signaling aptamers. Nat Biotechnol 18, 1293-1297.
73. Johnson, L., Gershon, P. D. (1999). RNA binding characteristics and overall topology of the vaccinia poly(A) polymerase-processivity factor-primer complex. Nucleic Acids Res 27, 2708-2721.
74. Kawakami, J., Imanaka, H., Yokota, Y., Sugimoto, N. (2000). In vitro selection of aptamers that act with Zn2+. J Inorg Biochem 82, 197-206.
75. Kikuchi, K., Umehara, T., Fukuda, K., Hwang, J., Kuno, A., Hasegawa, T., Nishikawa, S. (2003). RNA aptamers targeted to domain II of hepatitis C virus IRES that bind to its apical loop region. J Biochem 133, 263-270.
76. King, D. J., Bassett, S. E., Li, X., Fennewald, S. A., Herzog, N. K., Luxon, B. A., Shope, R., Gorenstein, D. G. (2002). Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50. Biochemistry 41, 9696-9706.
77. Kirby, R., Cho, E. J., Gehrke, B., Bayer, T., Park, Y. S., Neikirk, D. P., McDevitt, J. T., Ellington, A. D. (2004). Aptamer-based sensor arrays for the detection and quantitation of proteins. Anal Chem 76, 4066-4075.
78. Klussmann, S. (2006). The Aptamer Handbook: Functional Oligonucleotides and Their Applications, Wiley-VCH, Weinheim, Germany.
79. Klussmann, S., Nolte, A., Bald, R., Erdmann, V. A., Furste, J. P. (1996). Mirror-image RNA that binds d-adenosine. Nat Biotechnol 14, 1112-1115.
80. Kopylov, A. M., Spiridonova, V. A. (2000). Combinatorial chemistry of nucleic acids:SELEX. Mol Biol 34, 940-954.
81. Kusser, W. (2000). Chemically modified nucleic acid aptamers for in vitro selections:evolving evolution. J Biotechnol 74, 27-38.
82. Lai, R. Y., Plaxco, K. W., Heeger, A. J. (2007). Aptamer-based electrochemical detection of picomolar platelet-derived growth factor directly in blood serum. Anal Chem 79, 229-233.
83. Lee, J. F., Stovall, G. M., Ellington, A. D. (2006). Aptamer therapeutics advance. Curr Opin Chem Biol 10, 282-289.
84. Lee, Y. J., Lee, S. W. (2006). In vitro selection of cancer-specific RNA aptamers. J Microbiol Biotechnol 16, 1149-1153.
85. Li, W., Wang, K. M., Tan, W. H., Ma, C. B., Yang, X. H. (2007). Aptamer-based analysis of angiogenin by fluorescence anisotropy. Analyst 132, 107-113.
86. Liss, M., Petersen, B., Wolf, H., Prohaska, E. (2002). An aptamer-based quartz crystal protein biosensor. Anal Chem 74, 4488-4495.
87. Liu, J. J., Stormo, G. D. (2005). Combining SELEX with quantitative assays to rapidly obtain accurate models of protein-DNA interactions. Nucleic Acids Res 33, e141.
88. Liu, J. W., Lu, Y. (2006). Smart nanomaterials responsive to multiple chemical stimuli with controllable cooperativity. Adv Mater 18, 1667-1671.
89. Liu, J. W., Mazumdar, D., Lu, Y. (2006). A simple and sensitive "dipstick" test in serum based on lateral flow separation of aptamer-linked nanostructures. Angew Chem Int Ed Engl 45, 7955-7959.
90. Lupold, S. E., Hicke, B. J., Lin, Y., Coffey, D. S. (2002). Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 62, 4029-4033.
91. Maberley, D. (2005). Pegaptanib for neovascular age-related macular degeneration. Issues Emerg Health Technol 1-4.
92. Maehashi, K., Katsura, T., Kerman, K., Takamura, Y., Matsumoto, K., Tamiya, E. (2007). Label-free protein biosensor based on aptamer-modified carbon nanotube field-effect transistors. Anal Chem 79, 782-787.
93. Marro, M. L., Daniels, D. A., McNamee, A., Andrew, D. P., Chapman, T. D., Jiang, M. S., Wu, Z. N., Smith, J. L., Patel, K. K., Gearing, K. L. (2005). Identification of potent and selective RNA antagonists of the IFN-gamma-inducible CXCL10 chemokine. Biochemistry 44, 8449-8460.
94. Marshall, K. A., Ellington, A. D. (2000). In vitro selection of RNA aptamers. Methods Enzymol 318, 193-214.
95. Martell, R. E., Nevins, J. R., Sullenger, B. A. (2002). Optimizing aptamer activity for gene therapy applications using expression cassette SELEX. Mol Ther 6, 30-34.
96. Mendonsa, S. D., Bowser, M. T. (2004). In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal Chem 76, 5387-5392.
97. Misono, T. S., Kumar, P. K. R. (2005). Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Anal Biochem 342, 312-317.
98. Morris, K. N., Jensen, K. B., Julin, C. M., Weil, M., Gold, L. (1998). High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci U S A 95, 2902-2907.
99. Mosing, R. K., Mendonsa, S. D., Bowser, M. T. (2005). Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 77, 6107-6112.
100. Mukhopadhyay, R. (2005). Aptamers are ready for the spotlight. Anal Chem 77, 114A-118A.
101. Murphy, M. B., Fuller, S. T., Richardson, P. M., Doyle, S. A. (2003). An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucleic Acids Res 31, e110.
102. Ng, E. W. M., Adamis, A. P. (2006). Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases. Oligonucleotide Ther 1082, 151-171.
103. Nimjee, S. M., Rusconi, C. P., Harrington, R. A., Sullenger, B. A. (2005a). The potential of aptamers as anticoagulants. Trends Cardiovasc Med 15, 41-45.
104. Nimjee, S. M., Rusconi, C. P., Sullenger, B. A. (2005b). Aptamers: an emerging class of therapeutics. Annu Rev Med 56, 555-583.
105. Nitsche, A., Kurth, A., Dunkhorst, A., Panke, O., Sielaff, H., Junge, W., Muth, D., Scheller, F., Stocklein, W., Dahmen, C., Pauli, G., Kage, A. (2007). One-step selection of vaccinia virus binding DNA-aptamers by MonoLEX. BMC Biotechnol 7, doi:10.1186/1472-6750-7-48.
106. Ohuchi, S. P., Ohtsu, T., Nakamura, Y. (2006). Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface. Biochimie 88, 897-904.
107. Pan, W., Craven, R. C., Qiu, Q., Wilson, C. B., Wills, J. W., Golovine, S., Wang, J. F. (1995). Isolation of virus-neutralizing RNAs from a large pool of random sequences. Proc Natl Acad Sci U S A 92, 11509-11513.
108. Papamichael, K. I., Kreuzer, M. P., Guilbault, G. G. (2007). Viability of allergy (IgE) detection using an alternative aptamer receptor and electrochemical means. Sens Actuat B Chem 121, 178-186.
109. Patel, D. J. (1997). Structural analysis of nucleic acid aptamers. Curr Opin Chem Biol 1, 32-46.
110. Patel, D. J., Suri, A. K., Jiang, F., Jiang, L. C., Fan, P., Kumar, R. A., Nonin, S. (1997). Structure, recognition and adaptive binding in RNA aptamer complexes. J Mol Biol 272, 645-664.
111. Purschke, W. G., Eulberg, D., Buchner, K., Vonhoff, S., Klussmann, S. (2006). An l-RNA-based aquaretic agent that inhibits vasopressin in vivo. Proc Natl Acad Sci U S A 103, 5173-5178.
112. Que-Gewirth, N. S., Sullenger, B. A. (2007). Gene therapy progress and prospects: RNA aptamers. Gene Ther 14, 283-291.
113. Radrizzani, M., Broccardo, M., Solveyra, C. G., Bianchini, M., Reyes, G. B., Cafferata, E. G., Santa-Coloma, T. A. (1999). Oligobodies: bench made synthetic antibodies. Medicina (B Aires) 59, 753-758.
114. Rajendran, M., Ellington, A. D. (2003). In vitro selection of molecular beacons. Nucleic Acids Res 31, 5700-5713.
115. Ravelet, C., Grosset, C., Peyrin, E. (2006). Liquid chromatography, electrochromatography and capillary electrophoresis applications of DNA and RNA aptamers. J Chromatogr A 1117, 1-10.
116. Rhie, A., Kirby, L., Sayer, N., Wellesley, R., Disterer, P., Sylvester, I., Gill, A., Hope, J., James, W., Tahiri-Alaoui, A. (2003). Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Biol Chem 278, 39697-39705.
117. Rimmele, M., (2003). Nucleic acid aptamers as tools and drugs: recent developments. ChemBioChem 4, 963-971.
118. Roulet, E., Busso, S., Camargo, A. A., Simpson, A. J. G., Mermod, N., Bucher, P. (2002). High-throughput SELEX-SAGE method for quantitative modeling of transcription-factor binding sites. Nat Biotechnol 20, 831-835.
119. Rupcich, N., Nutiu, R., Li, Y. F., Brennan, J. D. (2006). Solid-phase enzyme activity assay utilizing an entrapped fluorescence-signaling DNA aptamer. Angew Chem Int Ed Engl 45, 3295-3299.
120. Rusconi, C. P., Roberts, J. D., Pitoc, G. A., Nimjee, S. M., White, R. R., Quick, G., Scardino, E., Fay, W. P., Sullenger, B. A. (2004). Antidote-mediated control of an anticoagulant aptamer in vivo. Nat Biotechnol 22, 1423-1428.
121. Schneider, D., Gold, L., Platt, T. (1993). Selective enrichment of RNA Species for tight-binding to Escherichia coli Rho-factor. FASEB J 7, 201-207.
122. Shangguan, D., Li, Y., Tang, Z. W., Cao, Z. H. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. Y. J., Tan, W. H. (2006). Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 103, 11838-11843.
123. Shimada, T., Fujita, N., Maeda, M., Ishihama, A. (2005). Systematic search for the Cra-binding promoters using genomic SELEX system. Genes Cells 10, 907-918.
124. Singer, B. S., Shtatland, T., Brown, D., Gold, L. (1997). Libraries for genomic SELEX. Nucleic Acids Res 25, 781-786.
125. Smith, D., Kirschenheuter, G. P., Charlton, J., Guidot, D. M., Repine, J. E. (1995). In-vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. Chem Biol 2, 741-750.
126. Stojanovic, M. N., de Prada, P., Landry, D. W. (2000). Fluorescent sensors based on aptamer self-assembly. J Am Chem Soc 122, 11547-11548.
127. Stoltenburg, R., Reinemann, C., Strehlitz, B. (2005). FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal Bioanal Chem 383, 83-91.
128. Stoltenburg, R., Reinemann, C., Strehlitz, B. (2007a). SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 24, 381-403.
129. Stoltenburg, R., Reinemann, C., Strehlitz, B. (2007b). Development of aptamers as new receptors for environmental biosensors. In Environmental Biotechnology, C. S. K. Mishra and A. A. Juwarkar, eds., APH Publishing, New Delhi, India, pp. 83-112.
130. Tang, J. J., Xie, J. W., Shao, N. S., Guo, L., Yan, Y. (2006a). Capillary electrophoresis as a tool for screening aptainer with high affinity and high specificity to ricin. Chem J Chin Univ Chin 27, 1840-1843.
131. Tang, J. J., Xie, J. W., Shao, N. S., Yan, Y. (2006b). The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods. Electrophoresis 27, 1303-1311.
132. Tang, J., Yu, T., Guo, L., Xie, J., Shao, N., He, Z. (2007a). In vitro selection of DNA aptamer against abrin toxin and aptamer-based abrin direct detection. Biosens Bioelectron 22, 2456-2463.
133. Tang, Z., Shangguan, D., Wang, K., Shi, H., Sefah, K., Mallikratchy, P., Chen, H. W., Li, Y., Tan, W. (2007b). Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem 79(13), 4900-4907.
134. Tombelli, S., Minunni, A., Luzi, E., Mascini, M. (2005). Aptamer-based biosensors for the detection of HIV-1 Tat protein. Bioelectrochemistry 67, 135-141.
135. Tsai, R. Y. L., Reed, R. R. (1998). Identification of DNA recognition sequences and protein interaction domains of the multiple-Zn-finger protein Roaz. Mol Cell Biol 18, 6447-6456.
136. Tucker, C. E., Chen, L. S., Judkins, M. B., Farmer, J. A., Gill, S. C., Drolet, D. W. (1999). Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys. J Chromatogr B 732, 203-212.
137. Tuerk, C., Gold, L. (1990). Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
138. Ulrich, H., Martins, A. H. B., Pesquero, J. B. (2004). RNA and DNA aptamers in cytomics analysis. Cytometry 59A, 220-231.
139. Ulrich, H., Trujillo, C. A., Nery, A. A., Alves, J. M., Majumder, P., Resende, R. R., Martins, A. H. (2006). DNA and RNA aptamers: from tools for basic research towards therapeutic applications. Comb Chem High Throughput Screen 9, 619-632.
140. Vater, A., Klussmann, S. (2003). Toward third-generation aptamers: spiegelmers and their therapeutic prospects. Curr Opin Drug Discov Dev 6, 253-261.
141. Vater, A., Jarosch, F., Buchner, K., Klussmann, S. (2003). Short bioactive spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: Tailored-SELEX. Nucleic Acids Res 31, e130.
142. Wang, C., Zhang, M., Yang, G., Zhang, D., Ding, H.,Wang, H., Fan, M., Shen, B., Shao, N. (2003). Single-stranded DNA aptamers that bind differentiated but not parental cells:subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol 102, 15-22.
143. Wen, J. D., Gray, D. M. (2004). Selection of genomic sequences that bind tightly to Ff gene 5 protein: primer-free genomic SELEX. Nucleic Acids Res 32, e182.
144. White, R., Rusconi, C., Scardino, E., Wolberg, A., Lawson, J., Hoffman, M., Sullenger, B. (2001). Generation of species cross-reactive aptamers using "toggle" SELEX. Mol Ther 4, 567-574.
145. White, R. R., Shan, S., Rusconi, C. P., Shetty, G., Dewhirst, M. W., Kontos, C. D., Sullenger, B. A. (2003). Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A 100, 5028-5033.
146. Wiegand, T. W., Williams, P. B., Dreskin, S. C., Jouvin, M. H., Kinet, J. P., Tasset, D. (1996). High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J Immunol 157, 221-230.
147. Williams, K. P., Liu, X. H., Schumacher, T. N., Lin, H. Y., Ausiello, D. A., Kim, P. S., Bartel, D. P. (1997). Bioactive and nuclease-resistant l-DNA ligand of vasopressin. Proc Natl Acad Sci U S A 94, 11285-11290.
148. Wilson, D. S., Szostak, J. W. (1999). In vitro selection of functional nucleic acids. Annu Rev Biochem 68, 611-647.
149. Wlotzka, B., Leva, S., Eschgfaller, B., Burmeister, J., Kleinjung, F., Kaduk, C., Muhn, P., Hess-Stump, H., Klussmann, S. (2002). In vivo properties of an anti-GnRH spiegelmer:an example of an oligonucleotide-based therapeutic substance class. Proc Natl Acad Sci U S A 99, 8898-8902.
150. Wochner, A., Cech, B., Menger, M., Erdmann, V. A., Glökler, J. (2007). Semi-automated selection of DNA aptamers using magnetic particle handling. Biotechniques 43, 344-353.
151. Wu, L. H., Curran, J. F. (1999). An allosteric synthetic DNA. Nucleic Acids Res 27, 1512-1516.
152. Xiao, Y., Lubin, A. A., Heeger, A. J., Plaxco, K. W. (2005a). Label-free electronic detection of thrombin in blood serum by using an aptamer-based sensor. Angew Chem Int Ed Engl 44, 5456-5459.
153. Xiao, Y., Piorek, B. D., Plaxco, K. W., Heeger, A. J. (2005b). A reagentless signal-on architecture for electronic, aptamer-based sensors via target-induced strand displacement. J Am Chem Soc 127, 17990-17991.
154. Yamamoto, R., Katahira, M., Nishikawa, S., Baba, T., Taira, K., Kumar, P. K. R. (2000). A novel RNA motif that binds efficiently and specifically to the Tat protein of HIV and inhibits the trans-activation by Tat of transcription in vitro and in vivo. Genes Cells 5, 371-388.
155. Yan, A. C., Bell, K. M., Breeden, M. M., Ellington, A. D. (2005). Aptamers: prospects in therapeutics and biomedicine. Front Biosci 10, 1802-1827.
156. Yang, X. B., Li, X., Prow, T. W., Reece, L. M., Bassett, S. E., Luxon, B. A., Herzog, N. K., Aronson, J., Shope, R. E., Leary, J. F., Gorenstein, D. G. (2003). Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers. Nucleic Acids Res 31, e54.
157. Yang, Y., Yang, D., Schluesener, H. J., Zhang, Z. (2007). Advances in SELEX and application of aptamers in the central nervous system. Biomol Eng.
158. Yoshida, W., Yokobayashi, Y. (2007). Photonic boolean logic gates based on DNA aptamers. Chem Commun 2, 195-197.
159. Zolotukhin, A. S., Michalowski, D., Smulevitch, S., Felber, B. K. (2001). Retroviral constitutive transport element evolved from cellular TAP(NXF1)-binding sequences. J Virol 75, 5567-5575.
160. Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31, 3406-3415.